Page last updated: 2024-09-05

sb 203580 and Abnormalities, Drug-Induced

sb 203580 has been researched along with Abnormalities, Drug-Induced in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hales, BF; Yan, J	1

Other Studies

1 other study(ies) available for sb 203580 and Abnormalities, Drug-Induced

Article	Year
p38 and c-Jun N-terminal kinase mitogen-activated protein kinase signaling pathways play distinct roles in the response of organogenesis-stage embryos to a teratogen. The Journal of pharmacology and experimental therapeutics, 2008, Volume: 326, Issue:3 Topics: Abnormalities, Drug-Induced; Animals; Embryo, Mammalian; Female; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Organogenesis; p38 Mitogen-Activated Protein Kinases; Pregnancy; Pyridines; Teratogens	2008

Article

Year

p38 and c-Jun N-terminal kinase mitogen-activated protein kinase signaling pathways play distinct roles in the response of organogenesis-stage embryos to a teratogen.

The Journal of pharmacology and experimental therapeutics, 2008, Volume: 326, Issue:3

Topics: Abnormalities, Drug-Induced; Animals; Embryo, Mammalian; Female; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Organogenesis; p38 Mitogen-Activated Protein Kinases; Pregnancy; Pyridines; Teratogens

2008